ArticleCancers2024

The Use of CA-125 KELIM to Identify Which Patients Can Achieve Complete Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Serous Advanced Ovarian Cancer.

Dimitrios Zouzoulas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.